Source:http://linkedlifedata.com/resource/pubmed/id/10084650
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-3-24
|
pubmed:abstractText |
The purpose of this study was to evaluate free-to-total prostate-specific antigen (PSA) ratios after definitive external beam radiation therapy for men with adenocarcinoma of the prostate (CaP).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-4790
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
91-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10084650-Adenocarcinoma,
pubmed-meshheading:10084650-Humans,
pubmed-meshheading:10084650-Male,
pubmed-meshheading:10084650-Prospective Studies,
pubmed-meshheading:10084650-Prostate-Specific Antigen,
pubmed-meshheading:10084650-Prostatic Neoplasms,
pubmed-meshheading:10084650-Radiotherapy Dosage
|
pubmed:year |
1999
|
pubmed:articleTitle |
Free-to-total prostate-specific antigen ratios 18-24 months following external beam radiation for adenocarcinoma of the prostate.
|
pubmed:affiliation |
Department of Urology, Naval Medical Center, San Diego, California 92134-5000, USA. jfward@snd10.med.navy.mil
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|